Variables | Group A (n = 115) N (%) | Group B (n = 106) N (%) | P value |
---|---|---|---|
Female sex | 42(36.5) | 32 (30.2) | 0.42 |
Age > 65 years | 78 (67.8) | 80 (75.5) | 0.11 |
Symptom status(stable) | 66 (57.4) | 70 (66.0) | 0.65 |
Diabetes | 35 (30.4) | 36 (34.0) | 0.77 |
Hypertension | 70 (60.9) | 79 (74.5) | 0.12 |
Hypercholesterolemia | 85 (73.9) | 76 (71.7) | 0.88 |
Smoking | 86 (74.8) | 72(67.9) | 0.61 |
Chronic Renal dysfunction | 4 (3.5) | 3 (2.8) | 0.08 |
Chronic Gastritis | 9 (7.8) | 10 (9.4) | 0.11 |
COPD | 16 (13.9) | 18 (17.0) | 0.47 |
Peripheral vascular disease | 7(6.1) | 5 (4.7) | 0.21 |
MI | 73 (63.5) | 79 (74.5) | 0.06 |
Angina (CCS III/IV) | 95 (82.6) | 84 (79.2) | 0.21 |
Dyspnea (NYHA III/IV) | 55(47.8) | 42 (39.6) | 0.18 |
Redo CABG | 2 (1.7) | 1(0.9) | 0.07 |
Prior CVA | 5 (4.3) | 3 (2.8) | 0.11 |
BMI > 30 kg/m2 | 45 (39.1) | 35 (33.0) | 0.45 |
Aspirin<10 days | 96 (83.5) | 78(73.6) | 0.17 |
Previous failed PTCA | 8 (7.0) | 8 (7.5) | 0.64 |
Parsonnet score >10 | 73 (63.5) | 73 (68.9) | 0.37 |
Left main disease | 20 (17.2) | 21 (19.8) | 0.58 |
Mean Diseased vessels | 3.20 ± 0.36 | 3.42 ± 0.52 | 0.85 |
Mean EuroSCORE | 12.58 ± 3.05 | 13.37 ± 3.13 | 0.26 |
Mean LVEF(%) | 29.62 ± 5.32 | 30.04 ± 4.27 | 0.36 |